Fabrizia Urbinati

2.4k citations

28 papers · 1.4k indexed · 1 hit paper · h-index 17

Business and International Management top 2%
Genetics top 5%
- Virus-based gene therapy research 17
- Hemoglobinopathies and Related Disorders 8
Genetics top 2%
- Virus-based gene therapy research 17
- Hemoglobinopathies and Related Disorders 8
Aging top 10%
Molecular Biology top 10%
- CRISPR and Genetic Engineering 13
- RNA Interference and Gene Delivery 4
- RNA regulation and disease 3
Infectious Diseases
- Parvovirus B19 Infection Studies 6
- Viral gastroenteritis research and epidemiology 2
Oncology
- CAR-T cell therapy research 5

Co-authors: Donald B. Kohn Punam Malik Tomoyasu Higashimoto Roger P. Hollis Fulvio Mavilio Paritha Arumugam Mark C. Walters Denise P. Muñoz
Cited by: Business and International Management Genetics
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)Blood (6 papers)
Partner nations: United States Italy France

In The Last Decade

Fabrizia Urbinati

28 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Fabrizia Urbinati

Since Specialization

Citations

This map shows the geographic impact of Fabrizia Urbinati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizia Urbinati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizia Urbinati more than expected).

Fields of papers citing papers by Fabrizia Urbinati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizia Urbinati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizia Urbinati. The network helps show where Fabrizia Urbinati may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fabrizia Urbinati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fabrizia Urbinati Line = papers co-authored together Fabrizia Urbinati links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia Molecular Therapy — Methods & Clinical Development ·Joshua C. Chang,Molly R. Ryan,Marie C. Stark,Su Liu,Pravinkumar Purushothaman,Fria Bolan,C. A. Johnson,Mark Champe,Hui Meng,Michael W. Lawlor,Sarah Halawani,Lucie Ngaba,David R. Lynch,Crystal Davis,Elena Gonzalo-Gil,Cathleen Lutz,Fabrizia Urbinati,Bala Medicherla,Carlos Fonck	2024	7
2	High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy The American Journal of Human Genetics ·Gaia Andreoletti,Oriana Romano,Hsin-Jung Chou,Mahjoubeh J. Sefid-Dashti,Andrea Grilli,Clarice Chen,Neema Lakshman,P. K. Pandey and C.S. Purushothaman,Fatbardha Varfaj,Fulvio Mavilio,Silvio Bicciato,Fabrizia Urbinati	2023	3
3	Gene Therapy for Sickle Cell Disease : A Lentiviral Vector Comparison Study Human Gene Therapy ·Fabrizia Urbinati,Beatriz Campo Fernandez,Katelyn E. Masiuk,Valentina Poletti,Roger P. Hollis,Colin Koziol,Michael L. Kaufman,Devin Brown,Fulvio Mavilio,Donald B. Kohn	2018	27
4	Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease Molecular Therapy — Methods & Clinical Development ·Valentina Poletti,Fabrizia Urbinati,Sabine Charrier,Guillaume Corre,Roger P. Hollis,Beatriz Campo Fernandez,Samia Martin,Michael Rothe,Axel Schambach,Donald B. Kohn,Fulvio Mavilio	2018	18
5	Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease Cytotherapy ·Fabrizia Urbinati,Jennifer Wherley,Sabine Geiger,Beatriz Campo Fernandez,Michael L. Kaufman,Aaron Cooper,Zulema Romero,Filippo Marchioni,Lilith Reeves,Elizabeth J. Read,Barbara Nowicki,Elke Grassman,Shiv Kumar Viswanathan,Xiaoyan Wang,Roger P. Hollis,Donald B. Kohn	2017	16
6	Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells Molecular Therapy ·Katelyn E. Masiuk,Devin Brown,Jennifer Laborada,Roger P. Hollis,Fabrizia Urbinati,Donald B. Kohn	2017	29
7	Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases Molecular Therapy — Nucleic Acids ·Carmen Flores,Michelle Mojadidi,John W. Phillips,Caroline Y. Kuo,Stephen Y. Lai,Georgia R. Lill,Aaron Cooper,Michael L. Kaufman,Fabrizia Urbinati,Xiaoyan Wang,Roger P. Hollis,Donald B. Kohn	2016	50
8	CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells Molecular Therapy ·Megan D. Hoban,Dianne Lumaquin,Caroline Y. Kuo,Zulema Romero,Joseph Long,Michelle Ho,Courtney S. Young,Michelle Mojadidi,Sorel Fitz‐Gibbon,Aaron Cooper,Georgia R. Lill,Fabrizia Urbinati,Beatriz Campo-Fernández,Carmen Flores,Matteo Pellegrini,Roger P. Hollis,Donald B. Kohn	2016	153
9	The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells Molecular Therapy — Methods & Clinical Development ·Zulema Romero,Beatriz Campo-Fernández,Jennifer Wherley,Michael L. Kaufman,Fabrizia Urbinati,Aaron Cooper,Megan D. Hoban,Kismet M Baldwin,Dianne Lumaquin,Xiaoyan Wang,Shantha Senadheera,Roger P. Hollis,Donald B. Kohn	2015	12
10	Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells Experimental Hematology ·Fabrizia Urbinati,Phillip W. Hargrove,Sabine Geiger,Zulema Romero,Jennifer Wherley,Michael L. Kaufman,Roger P. Hollis,Christopher B. Chambers,Derek A. Persons,Donald B. Kohn,Andrew Wilber	2015	27
11	Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy Stem Cells ·Kismet M Baldwin,Fabrizia Urbinati,Zulema Romero,Beatriz Campo-Fernández,Michael L. Kaufman,Aaron Cooper,Katelyn E. Masiuk,Roger P. Hollis,Donald B. Kohn	2015	25
12	Laser Tweezers Raman Spectroscopy As a Novel Red Blood Cell Functional Assay for Sickle Cell Disease Blood ·Rui Liu,Lena Zheng,Denis M. Dwyre,Fabrizia Urbinati,Donald B. Kohn,Dennis Matthews,James W. Chan,Noriko Satake	2011	2
13	Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3′LTR Molecular Therapy ·Fabrizia Urbinati,Paritha Arumugam,Tomoyasu Higashimoto,Anil Perumbeti,Kyle Mitts,Ping Xia,Punam Malik	2009	57
14	Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region Molecular Therapy ·Paritha Arumugam,Tomoyasu Higashimoto,Fabrizia Urbinati,Ute Modlich,Shawna Nestheide,Ping Xia,Catherine Fox,Andrea Corsinotti,Christopher Baum,Punam Malik	2009	61
15	The 3′ Region of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to Its Core and Is Required for Full Insulator Activity PLoS ONE ·Paritha Arumugam,Fabrizia Urbinati,Chinavenmeni S. Velu,Tomoyasu Higashimoto,H. Leighton Grimes,Punam Malik	2009	52
16	Mechanism of Reduction in Titers from Lentivirus Vectors Carrying Chromatin Insulator Elements in the 3′ LTR Blood ·Fabrizia Urbinati,Paritha Arumugam,Tomoyasu Higashimoto,Anil Perumbeti,Ping Xia,Punam Malik	2008	1
17	Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy Journal of Clinical Investigation ·Alessandro Aiuti,Barbara Cassani,Grazia Andolfi,Massimiliano Mirolo,Luca Biasco,Alessandra Recchia,Fabrizia Urbinati,Cristina Valacca,Samantha Scaramuzza,Memet Aker,Shimon Slavin,Matteo Cazzola,Daniela Sartori,Alessandro Ambrosi,Clelia Di Serio,Maria Grazia Roncarolo,Fulvio Mavilio,Claudio Bordignon	2007	180
18	The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors Gene Therapy ·Tomoyasu Higashimoto,Fabrizia Urbinati,Anil Perumbeti,Gang Jiang,Alexander Zarzuela,L-J Chang,Donald B. Kohn,Punam Malik	2007	63
19	Pathophysiology and therapy for haemoglobinopathies; Part II: thalassaemias Expert Reviews in Molecular Medicine ·Fabrizia Urbinati,Catherine Madigan,Punam Malik	2006	18
20	Competitive Engraftment of Hematopoietic Stem Cells Genetically Modified with a Truncated Erythropoietin Receptor Human Gene Therapy ·Fabrizia Urbinati,Francesco Lotti,Giulia Facchini,Monica Montanari,Giuliana Ferrari,Fulvio Mavilio,Alexis Grande	2005	12

About Fabrizia Urbinati

Fabrizia Urbinati is a scholar working on Genetics, Genetics and Infectious Diseases, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (13 papers), Hemoglobinopathies and Related Disorders (8 papers), Parvovirus B19 Infection Studies (6 papers), CAR-T cell therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), RNA regulation and disease (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Business and International Management (73 citations), Genetics (330 citations) and Genetics (785 citations). Fabrizia Urbinati has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Donald B. Kohn, Punam Malik, Tomoyasu Higashimoto, Roger P. Hollis, Fulvio Mavilio, Paritha Arumugam, Mark C. Walters, Denise P. Muñoz, Seok‐Jin Heo and Wendy Magis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact